LISI GROUP - Activity report 2019

What were the highlights of 2019? LISI MEDICAL experienced a strong rebound in its activity, with sales growth higher than that of the market as it reached 11.9% this year on a like-for-like and constant exchange rate basis. This dynamism stems primarily from the capital expenditures which have enabled us to meet and serve the needs of our customers It is also explained by the market share taken by LISI MEDICAL on the sectors where we are strategically positioned. First of all, the minimally invasive surgery market, where we have launched many products has contributed 70% to growth in this segment, and also in reconstructive orthopedics, where the division has become a major strategic player. LISI MEDICAL holds a key position in this highly concentrated segment and where the OEMs seek subcontractors capable of supplying large quantities of products, at the best cost, with a very high level of quality. How did the division behave? To meet these requirements, we have initiated a number of technical development and productivity plans which were continued in 2019. We have accelerated on robotization and we have strengthened our historical know-how in forging. This technology is difficult to master and makes us stand out from our competitors in the joint reconstruction markets such as hip, shoulder and knee prostheses. What will your strategy be in 2020? The strategy which guides our action today primarily relies on the search for operational excellence. It allows us to build a relationship of trust with our customers by serving them perfectly, both in the innovation and ramp-up phases. We also would like to consolidate and develop our historic relationship with our major global customers. Additionally, we will take advantage of the resilience of the minimally invasive surgery market, relying on the technical excellence of our Minneapolis site. Finally, we will rely on our new organization called One LISI MEDICAL: a specialized and connected industrial network served by a unique commercial structure in order to best serve our global customers. Questions to Jean-Marc DURANO Chief Executive Officer, LISI MEDICAL LISI MEDICAL has now become a major strategic supplier in a highly concentrated market.  79 LISI 2019